Talassemiya (Uzbek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Talassemiya" in Uzbek language version.

refsWebsite

Global rank Uzbek rank

17nih.gov

4^th place

7^th place

6web.archive.org

1^st place

6doi.org

2^nd place

3^rd place

2worldcat.org

5^th place

10^th place

2books.google.com

3^rd place

4^th place

1aamds.org

low place

1jcdr.net

low place

aamds.org

„Iron Chelation“. Qaraldi: 2020-yil 15-iyul.

books.google.com

Clin. Methods in Ped. (en). Jaypee Brothers Publishers, 2005 — 21 bet. ISBN 9788171798087. ^{[sayt ishlamaydi]}
Weatherall, D. J. „The Thalassemias: Disorders of Globin Synthesis“,. Williams Hematology, 9th, McGraw Hill Professional, 2015 — 725 bet. ISBN 9780071833011.

doi.org

Shah, Sandip; Sheth, Radhika; Shah, Kamlesh; Patel, Kinnari (February 2020). „Safety and effectiveness of thalidomide and hydroxyurea combination in β‐thalassaemia intermedia and major: a retrospective pilot study“. British Journal of Haematology (inglizcha). 188-jild, № 3. e18–e21-bet. doi:10.1111/bjh.16272. ISSN 0007-1048. PMID 31710694.
Keikhaei, Bijan (2015). „Clinical and Haematological Effects of Hydroxyurea in β -Thalassemia Intermedia Patients“. Journal of Clinical and Diagnostic Research. 9-jild, № 10. OM01-3-bet. doi:10.7860/JCDR/2015/14807.6660. PMC 4625280. PMID 26557561.
Masera, Nicoletta; Tavecchia, Luisa; Capra, Marietta; Cazzaniga, Giovanni; Vimercati, Chiara; Pozzi, Lorena; Biondi, Andrea; Masera, Giuseppe (2010). „Optimal response to thalidomide in a patient with thalassaemia major resistant to conventional therapy“. Blood Transfusion. 8-jild, № 1. 63–5-bet. doi:10.2450/2009.0102-09. ISSN 1723-2007. PMC 2809513. PMID 20104280.
Global Burden of Disease Study 2013 (22 August 2015). „Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013“. Lancet. 386-jild, № 9995. 743–800-bet. doi:10.1016/s0140-6736(15)60692-4. PMC 4561509. PMID 26063472.
GBD 2015 Mortality and Causes of Death (8 October 2016). „Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015“. Lancet. 388-jild, № 10053. 1459–1544-bet. doi:10.1016/s0140-6736(16)31012-1. PMC 5388903. PMID 27733281.
GBD 2013 Mortality and Causes of Death (17 December 2014). „Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013“. The Lancet. 385-jild, № 9963. 117–71-bet. doi:10.1016/S0140-6736(14)61682-2. PMC 4340604. PMID 25530442.

jcdr.net

Keikhaei, Bijan (2015). „Clinical and Haematological Effects of Hydroxyurea in β -Thalassemia Intermedia Patients“. Journal of Clinical and Diagnostic Research. 9-jild, № 10. OM01-3-bet. doi:10.7860/JCDR/2015/14807.6660. PMC 4625280. PMID 26557561.

nih.gov

nhlbi.nih.gov

„What Are Thalassemias?“. NHLBI (2012-yil 3-iyul). 2016-yil 26-avgustda asl nusxadan arxivlangan. Qaraldi: 2016-yil 5-sentyabr.
„What Are the Signs and Symptoms of Thalassemias?“. NHLBI (2012-yil 3-iyul). 2016-yil 16-sentyabrda asl nusxadan arxivlangan. Qaraldi: 2016-yil 5-sentyabr.
„What Causes Thalassemias?“. NHLBI (2012-yil 3-iyul). 2016-yil 26-avgustda asl nusxadan arxivlangan. Qaraldi: 2016-yil 5-sentyabr.
„How Are Thalassemias Diagnosed?“. NHLBI (2012-yil 3-iyul). 2016-yil 16-sentyabrda asl nusxadan arxivlangan. Qaraldi: 2016-yil 5-sentyabr.
„How Can Thalassemias Be Prevented?“. NHLBI (2012-yil 3-iyul). 2016-yil 16-sentyabrda asl nusxadan arxivlangan. Qaraldi: 2016-yil 5-sentyabr.
„How Are Thalassemias Treated?“. NHLBI (2012-yil 3-iyul). 2016-yil 16-sentyabrda asl nusxadan arxivlangan. Qaraldi: 2016-yil 5-sentyabr.

pubmed.ncbi.nlm.nih.gov

Shah, Sandip; Sheth, Radhika; Shah, Kamlesh; Patel, Kinnari (February 2020). „Safety and effectiveness of thalidomide and hydroxyurea combination in β‐thalassaemia intermedia and major: a retrospective pilot study“. British Journal of Haematology (inglizcha). 188-jild, № 3. e18–e21-bet. doi:10.1111/bjh.16272. ISSN 0007-1048. PMID 31710694.
Keikhaei, Bijan (2015). „Clinical and Haematological Effects of Hydroxyurea in β -Thalassemia Intermedia Patients“. Journal of Clinical and Diagnostic Research. 9-jild, № 10. OM01-3-bet. doi:10.7860/JCDR/2015/14807.6660. PMC 4625280. PMID 26557561.
Masera, Nicoletta; Tavecchia, Luisa; Capra, Marietta; Cazzaniga, Giovanni; Vimercati, Chiara; Pozzi, Lorena; Biondi, Andrea; Masera, Giuseppe (2010). „Optimal response to thalidomide in a patient with thalassaemia major resistant to conventional therapy“. Blood Transfusion. 8-jild, № 1. 63–5-bet. doi:10.2450/2009.0102-09. ISSN 1723-2007. PMC 2809513. PMID 20104280.
Global Burden of Disease Study 2013 (22 August 2015). „Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013“. Lancet. 386-jild, № 9995. 743–800-bet. doi:10.1016/s0140-6736(15)60692-4. PMC 4561509. PMID 26063472.
GBD 2015 Mortality and Causes of Death (8 October 2016). „Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015“. Lancet. 388-jild, № 10053. 1459–1544-bet. doi:10.1016/s0140-6736(16)31012-1. PMC 5388903. PMID 27733281.
GBD 2013 Mortality and Causes of Death (17 December 2014). „Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013“. The Lancet. 385-jild, № 9963. 117–71-bet. doi:10.1016/S0140-6736(14)61682-2. PMC 4340604. PMID 25530442.

ncbi.nlm.nih.gov

Keikhaei, Bijan (2015). „Clinical and Haematological Effects of Hydroxyurea in β -Thalassemia Intermedia Patients“. Journal of Clinical and Diagnostic Research. 9-jild, № 10. OM01-3-bet. doi:10.7860/JCDR/2015/14807.6660. PMC 4625280. PMID 26557561.
Masera, Nicoletta; Tavecchia, Luisa; Capra, Marietta; Cazzaniga, Giovanni; Vimercati, Chiara; Pozzi, Lorena; Biondi, Andrea; Masera, Giuseppe (2010). „Optimal response to thalidomide in a patient with thalassaemia major resistant to conventional therapy“. Blood Transfusion. 8-jild, № 1. 63–5-bet. doi:10.2450/2009.0102-09. ISSN 1723-2007. PMC 2809513. PMID 20104280.
Global Burden of Disease Study 2013 (22 August 2015). „Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013“. Lancet. 386-jild, № 9995. 743–800-bet. doi:10.1016/s0140-6736(15)60692-4. PMC 4561509. PMID 26063472.
GBD 2015 Mortality and Causes of Death (8 October 2016). „Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015“. Lancet. 388-jild, № 10053. 1459–1544-bet. doi:10.1016/s0140-6736(16)31012-1. PMC 5388903. PMID 27733281.
GBD 2013 Mortality and Causes of Death (17 December 2014). „Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013“. The Lancet. 385-jild, № 9963. 117–71-bet. doi:10.1016/S0140-6736(14)61682-2. PMC 4340604. PMID 25530442.

web.archive.org

„What Are Thalassemias?“. NHLBI (2012-yil 3-iyul). 2016-yil 26-avgustda asl nusxadan arxivlangan. Qaraldi: 2016-yil 5-sentyabr.
„What Are the Signs and Symptoms of Thalassemias?“. NHLBI (2012-yil 3-iyul). 2016-yil 16-sentyabrda asl nusxadan arxivlangan. Qaraldi: 2016-yil 5-sentyabr.
„What Causes Thalassemias?“. NHLBI (2012-yil 3-iyul). 2016-yil 26-avgustda asl nusxadan arxivlangan. Qaraldi: 2016-yil 5-sentyabr.
„How Are Thalassemias Diagnosed?“. NHLBI (2012-yil 3-iyul). 2016-yil 16-sentyabrda asl nusxadan arxivlangan. Qaraldi: 2016-yil 5-sentyabr.
„How Can Thalassemias Be Prevented?“. NHLBI (2012-yil 3-iyul). 2016-yil 16-sentyabrda asl nusxadan arxivlangan. Qaraldi: 2016-yil 5-sentyabr.
„How Are Thalassemias Treated?“. NHLBI (2012-yil 3-iyul). 2016-yil 16-sentyabrda asl nusxadan arxivlangan. Qaraldi: 2016-yil 5-sentyabr.

worldcat.org

Shah, Sandip; Sheth, Radhika; Shah, Kamlesh; Patel, Kinnari (February 2020). „Safety and effectiveness of thalidomide and hydroxyurea combination in β‐thalassaemia intermedia and major: a retrospective pilot study“. British Journal of Haematology (inglizcha). 188-jild, № 3. e18–e21-bet. doi:10.1111/bjh.16272. ISSN 0007-1048. PMID 31710694.
Masera, Nicoletta; Tavecchia, Luisa; Capra, Marietta; Cazzaniga, Giovanni; Vimercati, Chiara; Pozzi, Lorena; Biondi, Andrea; Masera, Giuseppe (2010). „Optimal response to thalidomide in a patient with thalassaemia major resistant to conventional therapy“. Blood Transfusion. 8-jild, № 1. 63–5-bet. doi:10.2450/2009.0102-09. ISSN 1723-2007. PMC 2809513. PMID 20104280.